Steven A Feldman

Years Active: 2022-2024
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Hrishikesh Krishna Srinagesh, Clayton Jackson, Parveen Shiraz, Nikeshan Jeyakumar, Mark P Hamilton, Emily Egeler, Sharon Mavroukakis, Adam Kuo, Juancarlos Cancilla, Bita Sahaf, Neha Agarwal, Alyssa M Kanegai, Anne Marijn Kramer, Sally Arai, Sushma Bharadwaj, Saurabh Dahiya, Hitomi Hosoya, Laura J Johnston, Vanessa E Kennedy, Michaela Liedtke, Robert Lowsky, Lekha Mikkilineni, Robert S Negrin, Andrew R Rezvani, Surbhi Sidana, Judith A Shizuru, Melody Smith, Wen-Kai Weng, Steven A Feldman, Matthew J Frank, Zachary Lee, Mary Tagliaferri, A Mario Q Marcondes, David Bernard Miklos, Crystal L Mackall, Lori S Muffly
A Phase 1 Clinical Trial of NKTR-255 with CD19-22 CAR-T Cell Therapy for Refractory B-cell Acute Lymphoblastic Leukemia. Blood (2024)
Nikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, Sanghyun P Kim, Jared J Gartner, Sivasish Sindiri, Victoria K Hill, Yong F Li, Biman C Paria, Satyajit Ray, Billel Gasmi, Chyi-Chia Lee, Todd D Prickett, Maria R Parkhurst, Paul F Robbins, Michelle M Langhan, Thomas E Shelton, Anup Y Parikh, Shoshana T Levi, Jonathan M Hernandez, Chuong D Hoang, Richard M Sherry, James C Yang, Steven A Feldman, Stephanie L Goff, Steven A Rosenberg
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (16) (2022)

Steven A Feldman.css-eqlu8i{font-size:small;padding-left:4px;}